{"schema_version":"1","generated_at":"2026-10-28T20:51:18.218Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ming-sheng-lee","json_url":"https://www.findmykol.com/kol/ming-sheng-lee/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ming-sheng-lee","name":"Ming-Sheng Lee","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1235239468","openalex":"A5111681900"},"summary":"Ming-Sheng Lee is a Hematology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 11 publications with 1,292 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":11,"cited_by_count":1292,"h_index":8,"latest_activity_year":2007,"source":"works"},"funding":{"award_count":2,"fiscal_years":{"first":1989,"last":1997},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P01CA049639","title":"CLINICAL STUDIES OF PCR POSITIVITY IN CML","fiscal_year":1997,"organization":"UNIVERSITY OF TEXAS MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/P01CA049639"},{"project":"R01CA049443","title":"MINIMAL RESIDUAL DISEASE IN LYMPHOMAS WITH THE T-14-18","fiscal_year":1993,"organization":"UNIVERSITY OF TEXAS MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA049443"},{"project":"R01CA049443","title":"MINIMAL RESIDUAL DISEASE IN LYMPHOMAS WITH THE T-14-18","fiscal_year":1992,"organization":"UNIVERSITY OF TEXAS MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA049443"}],"source":"grants"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"OpenAlex author record","recent":[{"title":"Polymerase Chain Reaction and Sequencing of Immunoglobulin Heavy Chain Gene Rearrangement in Formalin Fixed, Paraffin-embedded Tissue of Patients with B Cell Lymphoma","year":2007,"journal":"The Korean Journal of Hematology","source_url":"https://doi.org/10.5045/kjh.2007.42.4.361","status":"verified"},{"title":"Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center","year":2006,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2005.03.3696","status":"verified"},{"title":"Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival","year":2004,"journal":"Experimental Hematology","source_url":"https://doi.org/10.1016/j.exphem.2003.09.021","status":"verified"},{"title":"Molecular Response of Follicular Lymphoma to Cyclophosphamide, Doxorubicin, Vincristine, Prednisone C(H)OP or COP-Based Therapy as Measured by Polymerase Chain Reaction Evidence of Translocation (14;18)(q32;q21)","year":2004,"journal":"The Cancer Journal","source_url":"https://doi.org/10.1097/00130404-200401000-00010","status":"verified"},{"title":"Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma","year":2002,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2001-12-0269","status":"verified"}],"source":"works"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":3,"publications":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}